ARCHIVES

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

Millers Win Bristol-Myers $25,000 Award

May 19, 1978

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

November 5, 1976

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

Former NCI Executive Lands Key Senate Staff Position

February 4, 1977

Brothers Of Prostate Cancer Patients At Risk Of Diagnosis

August 27, 2010

NCI plans 11-16 percent budget cuts in new grants to maintain R01 payline at 20th percentile.

November 28, 2003